Pope Asset Management’s China Pharma Holdings CPHI Stock Holding History

Pope Asset Management’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$289K	Hold	3,346	–	–	0.19%	23
2017 Q3	$292K	Hold	3,346	–	–	0.19%	20
2017 Q2	$384K	Sell	3,346 -857	-20%	-$96.9K	0.28%	21
2017 Q1	$546K	Hold	4,203	–	–	0.35%	21
2016 Q4	$546K	Hold	4,203	–	–	0.4%	19
2016 Q3	$451K	Buy	+4,203	New	+$538K	0.36%	18
2016 Q1	$357K	Hold	4,210	–	–	0.3%	19
2015 Q4	$317K	Hold	4,210	–	–	0.26%	21
2015 Q3	$716K	Hold	4,210	–	–	0.45%	21
2015 Q2	$757K	Hold	4,210	–	–	0.62%	16
2015 Q1	$716K	Hold	4,210	–	–	0.61%	15
2014 Q4	$632K	Hold	4,210	–	–	0.51%	16
2014 Q3	$528K	Buy	4,210 +1,887	+81%	+$272K	0.32%	16
2014 Q2	$461K	Sell	2,323 -1,971	-46%	-$410K	0.26%	18
2014 Q1	$1.08M	Sell	4,294 -1	-0%	-$276	0.62%	16
2013 Q4	$740K	Sell	4,295 -48	-1%	-$8.09K	1.02%	8
2013 Q3	$608K	Sell	4,343 -20	-0.5%	-$2.31K	0.86%	8
2013 Q2	$458K	Buy	+4,363	New	+$509K	0.76%	10

Other funds holding CPHI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Pope Asset Management's CPHI Position: Q4 2017 in Review

Pope Asset Management held its China Pharma Holdings (CPHI) position steady in Q4 2017 at 3,346 shares worth $289K. The position accounts for 0.19% of the portfolio, ranked #23.

Pope Asset Management first reported a position in CPHI in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.08M in Q1 2014. 8 funds tracked by Wall St. Rank hold CPHI as of Q4 2017.

Pope Asset Management held 3,346 shares of China Pharma Holdings worth $289K as of Q4 2017.
Pope Asset Management left its China Pharma Holdings share count unchanged in Q4 2017.
China Pharma Holdings made up 0.19% of Pope Asset Management's portfolio in Q4 2017, its #23 holding.
Pope Asset Management first reported a position in China Pharma Holdings in Q2 2013 and has held it in 18 quarters since.
Pope Asset Management's China Pharma Holdings position peaked at $1.08M in Q1 2014.
8 funds tracked by Wall St. Rank held China Pharma Holdings as of Q4 2017.

Based on Pope Asset Management's 13F filing for Q4 2017, filed 23 Feb 2018.